KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Adaptive Biotechnologies (ADPT) Gross Profit: 2017-2024

Historic Gross Profit for Adaptive Biotechnologies (ADPT) over the last 8 years, with Dec 2024 value amounting to $94.2 million.

  • Adaptive Biotechnologies' Gross Profit rose 172.38% to $70.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $161.1 million, marking a year-over-year increase of 74.73%. This contributed to the annual value of $94.2 million for FY2024, which is 15.30% up from last year.
  • Latest data reveals that Adaptive Biotechnologies reported Gross Profit of $94.2 million as of FY2024, which was up 15.30% from $81.7 million recorded in FY2023.
  • In the past 5 years, Adaptive Biotechnologies' Gross Profit ranged from a high of $94.2 million in FY2024 and a low of $37.0 million during FY2020.
  • In the last 3 years, Adaptive Biotechnologies' Gross Profit had a median value of $89.7 million in 2022 and averaged $88.5 million.
  • As far as peak fluctuations go, Adaptive Biotechnologies' Gross Profit fell by 20.58% in 2020, and later spiked by 59.03% in 2021.
  • Over the past 5 years, Adaptive Biotechnologies' Gross Profit (Yearly) stood at $37.0 million in 2020, then soared by 59.03% to $58.9 million in 2021, then soared by 52.35% to $89.7 million in 2022, then fell by 8.93% to $81.7 million in 2023, then increased by 15.30% to $94.2 million in 2024.